A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
- Status
- SUSPENDED
- Phase
- PHASE1
A Study of Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102)
- Status
- COMPLETED
- Phase
- PHASE2
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM)
- Status
- COMPLETED
- Phase
- PHASE2
Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
- Status
- RECRUITING
- Phase
- PHASE2
Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3